Standex International Corporation (SXI) Stock Analysis
Is SXI a good investment?
Standex International Corporation (SXI) has a Plutrex AI rating of 62.5/100 as of October 12, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: Gross margin of 41.65% is 30% above the 32.03% industry average, demonstrating genuine pricing power and product differentiation in sensors, magnetics, and engineering technologies — not a commodity business. Main concern: Revenue growth of 2.8% is 77.9% below the 12.68% industry average — EPS growth of 19.1% driven primarily by margin expansion and buybacks rather than top-line compounding is mathematically unsustainable; if revenue does not accelerate, P/E of 32.88x will compress toward the industry average of 29.61x or below, implying 10%+ downside from current levels.
Investment Summary
Standex International (SXI) at $285.01 is a quality industrial compounder trading at a stretched valuation that offers no margin of safety at current prices. The P/E of 32.88x on revenue growth of only 2.8% (vs. industry peers averaging 12.68%) is the central tension: the stock prices in optimistic execution on 19.1% next-year EPS growth, yet the top-line fundamentals do not independently support this multiple. Gross margin of 41.65% (vs. 32.03% industry average — a 30% premium) and operating margin of 17.77% (vs. 16.17% peers) confirm genuine product differentiation and pricing power. However, ROE of 14.29% is 30.6% below the 20.59% industry average despite carrying above-peer leverage (D/E 0.73 vs. 0.547 industry), revealing suboptimal asset productivity. The analyst consensus target of $350.00 implies 22.8% upside but embeds the optimistic EPS scenario fully. Q4 FY2026 earnings of $2.45/share beat the $2.35 consensus estimate by $0.10, and record adjusted EPS for fiscal 2026 confirm near-term execution quality. News sentiment of 94/100 is strongly supportive but does not alter the valuation math. This is a Hold at $285.01 and a Buy in the $258–$272 entry zone.
Key Strengths
- Gross margin of 41.65% is 30% above the 32.03% industry average, demonstrating genuine pricing power and product differentiation in sensors, magnetics, and engineering technologies — not a commodity business
- Next-year forward EPS growth of 19.1% is 131% above the industry average of 8.27%, confirmed by Q4 FY2026 record adjusted EPS and a $0.10 beat vs. consensus — near-term earnings momentum is exceptional and validated by recent results
- 248+ consecutive quarterly dividends and consistent growth policy (referenced in dividend growth headline) signal extraordinary capital discipline and management durability, supported by $181M cash buffer
Key Concerns
- Revenue growth of 2.8% is 77.9% below the 12.68% industry average — EPS growth of 19.1% driven primarily by margin expansion and buybacks rather than top-line compounding is mathematically unsustainable; if revenue does not accelerate, P/E of 32.88x will compress toward the industry average of 29.61x or below, implying 10%+ downside from current levels
- ROE of 14.29% is 30.6% below the 20.59% industry average despite above-peer leverage (D/E 0.73 vs. 0.547) — this counterintuitive combination means SXI is taking more financial risk to generate below-peer returns on equity, and the P/B of 4.55x demands ROE expansion to 20%+ that is not yet visible in the data
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
SXI's fundamentals tell a bifurcated story. Profitability is above average: gross margin 41.65% vs. industry 32.03% (+30%), operating margin 17.77% vs. 16.17% (+9.9%), but net margin 11.74% trails the 12.07% industry average (-2.7%) due to higher interest burden from D/E of 0.73 vs. 0.547 industry norm. ROE of 14.29% is 30.6% below the 20.59% industry average — a critical deficiency that undermines the P/B of 4.55x. FCF of $50.2M is positive but thin relative to implied market cap (~$1.65B at $285/share), yielding roughly 3% FCF yield. Revenue growth of 2.8% is only 22% of the 12.68% industry average — the most severe structural underperformance. Next-year EPS growth of 19.1% (more than double the 8.27% industry average) is the primary near-term catalyst, but the 5-year forward EPS growth of 12.85% trails the 16.74% industry average, suggesting the acceleration may be partly one-time. At P/E 32.88x, the implied near-term PEG is 1.72x (near-term growth: 19.1%), still above fair value, and the long-term PEG is 2.57x (5yr growth: 12.85%) — meaningfully elevated. Cash of $181M provides adequate liquidity. The financial health score of 42/100 reflects the leverage-FCF mismatch.
News Sentiment
Standex International just delivered a standout finish to its fiscal year, and Wall Street noticed. The industrial technology company — known for sensors, magnetics, and engineering systems used in everything from power grids to defense — reported record fourth-quarter adjusted earnings per share for fiscal 2026, with Q4 EPS of $2.45 beating the analyst estimate of $2.35 by $0.10, according to the 'Standex International (SXI) Tops Q4 Earnings and Revenue Estimates' report. That's the kind of consistent execution that keeps long-term investors loyal. The 'Standex International Q4 Earnings Call Highlights' pointed to exposure to secular growth themes — grid modernization, defense spending, and the space economy — as catalysts that could finally push the company's sluggish 2.8% revenue growth higher in coming years. Meanwhile, the company reinforced its reputation as a dividend stalwart, appearing alongside ExxonMobil and Visa in a roundup of '16 Dividend Growth Companies To Announce Annual Dividend Increases' — a remarkable distinction for a mid-cap industrial. The good news? The business is clearly well-run. The caution? As 'Standex International: Strong Fundamentals, Premium Valuation' bluntly noted, the stock's P/E of nearly 33x already prices in perfection. For patient investors, the story is compelling — but the right entry price, not the current one, is where the real opportunity lies.
Risk Assessment
Primary risk: multiple compression. At P/E 32.88x on 2.8% revenue growth, any disappointment in the 19.1% next-year EPS trajectory — whether from macro headwinds, defense/grid modernization project delays, or capacity cost overruns — could trigger a re-rating toward the industry average P/E of 29.61x, implying a price of approximately $257 (10% downside from current). Secondary risk: leverage. D/E of 0.73 vs. 0.547 industry average means rising interest rates or credit tightening disproportionately impacts SXI's net margin (already below peers at 11.74% vs. 12.07%). Mitigation: the $181M cash cushion and positive FCF ($50.2M) provide a meaningful buffer. Secular tailwinds in grid modernization, defense spending, and space exposure (per earnings call highlights) provide upside optionality if revenue growth accelerates toward peers. Stop at $245 represents approximately 7.5% risk from entry at $265, sitting below key support and limiting downside to a defined level.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is SXI a halal stock?
No, Standex International Corporation (SXI) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for SXI?
Standex International Corporation (SXI) has a Plutrex AI rating of 62.5/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is SXI a good investment?
According to Plutrex AI, SXI has a Hold rating (62.5/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in SXI?
US stocks like SXI can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in SXI?
Plutrex AI identifies the main risks for SXI by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.